Brief: Medigene AG Says Amends 2022 Financial Guidance
10/03/2023 17:06
March 10 (Reuters) - Medigene AG MDG1k.DE :
* PTA-ADHOC: MEDIGENE AG: MEDIGENE AMENDS 2022 FINANCIAL
GUIDANCE
* MAINTAINS ITS GUIDANCE ON EXPECTED REVENUES TO BE
APPROXIMATELY
EUR 30-32 MILLION IN 2022.
* RESEARCH AND DEVELOPMENT COSTS WILL INCREASE FROM PRIOR
ESTIMATES OF EUR 12-14 MILLION TO EUR 28-29 MILLION FOR FY
* MEDIGENE - 2022 ESTIMATES FOR EBITDA REMAIN UNCHANGED AND
ARE
EXPECTED AT EUR 12-14 MILLION
Source text for Eikon: ID:nPexrJrt7a
Further company coverage: MDG1k.DE
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Medigene AG
See all newsBrief: Medigene Files Application For The Opening Of Insolvency Proceedings
Brief: Medigene Files Patent For Unique Nk-Specific TCR Construct With European Patent Office
Brief: Medigene AG Says Co Amends Financial Guidance For 2024
Brief: Medigene AG Expands Protection Of KRAS Library With Filing Of New Patent Application
Brief: Medigene H1 Revenue EUR 4.5 Million